Cellular Biomedicine Group, Inc. - FORM 10-K - EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - March 13, 2017

Attached files

file filename
EX-10.57 - EMPLOYMENT AGREEMENT, DATED MARCH 3, 2017, BY AND BETWEEN THE COMPANY AND ANDREW - Cellular Biomedicine Group, Inc.cbmg_ex1057.htm
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Cellular Biomedicine Group, Inc.cbmg_ex31.htm
EX-23.2 - CONSENTS OF EXPERTS AND COUNSEL - Cellular Biomedicine Group, Inc.cbmg_232.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - Cellular Biomedicine Group, Inc.cbmg_231.htm
EX-10.60 - LEASE AGREEMENT, DATED NOVEMBER 16, 2016, BY AND BETWEEN CBMG SHANGHAI AND SHANG - Cellular Biomedicine Group, Inc.cbmg_ex1060.htm
EX-10.59 - LEASE AGREEMENT, DATED NOVEMBER 16, 2016, BY AND BETWEEN CBMG SHANGHAI AND SHANG - Cellular Biomedicine Group, Inc.cbmg_ex1059.htm
EX-10.58 - EMPLOYMENT AGREEMENT, DATED MARCH 3, 2017, BY AND BETWEEN THE COMPANY AND YIHONG - Cellular Biomedicine Group, Inc.cbmg_ex1058.htm
EX-10.56 - EMPLOYMENT AGREEMENT, DATED MARCH 3, 2017, BY AND BETWEEN THE COMPANY AND BIZUO - Cellular Biomedicine Group, Inc.cbmg_ex1056.htm
EX-10.48 - LEASE AGREEMENT, DATED JANUARY 1, 2017, BY AND BETWEEN CBMG SHANGHAI AND SHANGHA - Cellular Biomedicine Group, Inc.cbmg_ex1048.htm
10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc.cbmg10-k.htm
 
Exhibit 32
 
CERTIFICATION
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
 
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Cellular Biomedicine Group, Inc., a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
 
The Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
Dated: March 13, 2017
By:
/s/ Bizuo (Tony) Liu
 
 
 
Bizuo (Tony) Liu
 
 
 
Chief Executive Officer and Chief Financial Officer
 
 
 
(principal executive officer and financial and accounting officer)
 
 
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of Form 10-K or as a separate disclosure document.
 
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
 

Stock widget

Investing forum

Cellular Biomedicine Group, Inc. Reports